Recommendations underscore the importance of confirming the patient's reproductive stage so that appropriate care can be provided.
Sponsoring Organizations: North American Menopause Society, National Network of Depression Centers–Women and Mood Disorders Task GroupTarget Audience: Women's healthcare providers
Background
Recent decades have seen increasing recognition of mood symptoms related to hormonal changes experienced by premenstrual, postpartum, and perimenopausal women. These guidelines are designed to assist clinicians caring for women with depression during the menopausal transition.
Key Recommendations
The perimenopause is a time of excess risk for depressive symptoms and major depressive episodes (MDEs), even in women without histories of major depressive disorder (MDD).
Risk factors for depressive symptoms during the perimenopause include prior MDD, black race, …
Reviewing Author
DisclosuresRoyaltiesUpToDate
Grant/Research SupportMerck, Mithra, Medicines360
Editorial BoardsContraception; Menopause; Contraceptive Technology Update; OBG Management; Medscape OB/GYN & Women’s Health
DisclosuresRoyaltiesUpToDate
Grant/Research SupportMerck, Mithra, Medicines360
Editorial BoardsContraception; Menopause; Contraceptive Technology Update; OBG Management; Medscape OB/GYN & Women’s Health